Study of the Safety, Efficacy and Cycle Control of a Contraceptive Vaginal Ring

NCT00455156 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1200

Enrollment

OTHER

Sponsor class

Conditions

Contraception

Interventions

DRUG: 150 mg of Nestorone and 15 mg of ethinyl estradiol (150/15 NES/EE CVR)

Sponsor

Premier Research

Collaborators

Population Council
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)